Delivering rhCC16 to the lung limited the progression of CS-induced emphysema, SAF, and CB-like disease in WT and Cc16–/– mice, in part, by reducing the pulmonary inflammatory response to CS. This evidence concerns the gene SCGB1A1 and Cowden syndrome 1.